July launch for Eurand/GSK's novel lamotrigine tablet
This article was originally published in Scrip
Executive Summary
Two of Eurand's technologies, its AdvaTab orally-disintegrating tablet and Microcaps, its taste-masking process, are used in GlaxoSmithKline's new oral formulation of lamotrigine, Lamictal ODT, which was approved for marketing earlier this month in the US.